Bvf I Gp Llc - Net Worth and Insider Trading
Bvf I Gp Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bvf I Gp Llc owns 25 companies in total, including Five Prime Therapeutics Inc () , Eledon Pharmaceuticals Inc () , and XOMA Corp () among others .
Click here to see the complete history of Bvf I Gp Llc’s form 4 insider trades.
Insider Ownership Summary of Bvf I Gp Llc
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Five Prime Therapeutics Inc | 2020-10-06 | 10 percent owner | |
Eledon Pharmaceuticals Inc | 2020-10-01 | other: See Explanation of Responses | |
XOMA Corp | 2020-03-13 | 10 percent owner | |
Merus NV | 2020-06-01 | other: See Explanation of Responses | |
Kymera Therapeutics Inc | 2021-06-16 | other: See Explanation of Responses | |
Principia Biopharma Inc | 2020-08-18 | other: See Explanation of Responses | |
IDEAYA Biosciences Inc | 2020-06-18 | other: See Explanation of Responses | |
CTI BioPharma Corp | 2020-03-02 | 10 percent owner | |
XOMA Corp | 2020-03-13 | 10 percent owner | |
Cytokinetics Inc | 2020-11-12 | other: See Explanation of Responses | |
Infinity Pharmaceuticals Inc | 2021-01-22 | other: See Explanation of Responses | |
GlycoMimetics Inc | 2020-10-30 | other: See Explanation of Responses | |
CytomX Therapeutics Inc | 2020-12-18 | other: See Explanation of Responses | |
Verastem Inc | 2022-01-25 | other: See Explanation of Responses | |
Rain Oncology Inc | 2021-04-22 | other: See Explanation of Responses | |
Olema Pharmaceuticals inc | 2020-11-18 | 10 percent owner | |
Cullinan Oncology Inc | 2021-12-31 | other: See Explanation of Responses | |
Repare Therapeutics Inc | 2021-10-28 | other: See Explanation of Responses | |
MoonLake Immunotherapeutics | 2022-04-05 | director & 10 percent owner | |
4D Molecular Therapeutics Inc | 2022-06-16 | other: See Explanation of Responses | |
ESSA Pharma Inc | 2022-07-11 | 10 percent owner | |
Third Harmonic Bio Inc | 2022-12-19 | other: See Explanation of Responses | |
Structure Therapeutics Inc | 2023-02-03 | other: See Explanation of Responses | |
Pieris Pharmaceuticals Inc | 2023-05-11 | 10 percent owner | |
POINT Biopharma Global Inc | 2023-11-02 | other: See Explanation of Responses |
Bvf I Gp Llc Trading Performance
Bvf I Gp Llc Ownership Network
Ownership Network List of Bvf I Gp Llc
Ownership Network Relation of Bvf I Gp Llc
Bvf I Gp Llc Owned Company Details
What does Five Prime Therapeutics Inc do?
Who are the key executives at Five Prime Therapeutics Inc?
Bvf I Gp Llc is the 10 percent owner of Five Prime Therapeutics Inc. Other key executives at Five Prime Therapeutics Inc include 10 percent owner Biotechnology Value Fund L P , 10 percent owner Bvf Partners L P/il , and 10 percent owner Bvf Inc/il .
Five Prime Therapeutics Inc () Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Five Prime Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Five Prime Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Five Prime Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Five Prime Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Eledon Pharmaceuticals Inc do?
Who are the key executives at Eledon Pharmaceuticals Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Eledon Pharmaceuticals Inc. Other key executives at Eledon Pharmaceuticals Inc include other: See Explanation of Responses Biotechnology Value Fund L P , director & See Remarks Steven Perrin , and director & Chief Executive Officer David-alexandre C Gros .
Eledon Pharmaceuticals Inc () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Eledon Pharmaceuticals Inc (). Other recent insider transactions involving Eledon Pharmaceuticals Inc () include a net purchase of 1,978,932 shares made by Biotechnology Value Fund L P , and a net purchase of 1,000 shares made by Steven Perrin .
In summary, during the past 3 months, insiders sold 0 shares of Eledon Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eledon Pharmaceuticals Inc () were sold and 1,979,932 shares were bought by its insiders, resulting in a net purchase of 1,979,932 shares.
Eledon Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Eledon Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does XOMA Corp do?
Who are the key executives at XOMA Corp?
Bvf I Gp Llc is the 10 percent owner of XOMA Corp. Other key executives at XOMA Corp include Chief Investment Officer Bradley Sitko , director & Interim CEO Owen Hughes , and other: See Explanation of Responses Biotechnology Value Fund L P .
XOMA Corp () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in XOMA Corp (). Other recent insider transactions involving XOMA Corp () include a net purchase of 9,100 shares made by Bradley Sitko , a net purchase of 5,500 shares made by Owen Hughes , and a net purchase of 22,249 shares made by Biotechnology Value Fund L P .
In summary, during the past 3 months, insiders sold 0 shares of XOMA Corp () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XOMA Corp () were sold and 36,849 shares were bought by its insiders, resulting in a net purchase of 36,849 shares.
XOMA Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.
XOMA Corp Insider Transactions
- Download to Excel(.xls)
What does Merus NV do?
Who are the key executives at Merus NV?
Bvf I Gp Llc is the other: See Explanation of Responses of Merus NV. Other key executives at Merus NV include Chief Accounting Officer Harry Shuman , EVP & General Counsel Peter B. Silverman , and director & President & CEO & PFO Sven Ante Lundberg .
Merus NV () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Merus NV (). Other recent insider transactions involving Merus NV () include a net sale of 2,258 shares made by Harry Shuman , a net sale of 22,386 shares made by Peter B. Silverman , and a net purchase of 14,706 shares made by Sven Ante Lundberg .
In summary, during the past 3 months, insiders sold 0 shares of Merus NV () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 24,644 shares of Merus NV () were sold and 14,706 shares were bought by its insiders, resulting in a net sale of 9,938 shares.
Merus NV ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Merus NV Insider Transactions
- Download to Excel(.xls)
What does Kymera Therapeutics Inc do?
Who are the key executives at Kymera Therapeutics Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Kymera Therapeutics Inc. Other key executives at Kymera Therapeutics Inc include 10 percent owner Atlas Venture Fund X, L.p. , Chief Medical Officer Jared Gollob , and Chief Financial Officer Bruce N. Jacobs .
Kymera Therapeutics Inc () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Kymera Therapeutics Inc (). Other recent insider transactions involving Kymera Therapeutics Inc () include a net sale of 1,498,336 shares made by Bruce Booth , a net sale of 1,370,793 shares made by Atlas Venture Fund X, L.p. , and a net sale of 49,881 shares made by Jared Gollob .
In summary, during the past 3 months, insiders sold 903,072 shares of Kymera Therapeutics Inc () in total and bought 0 shares, with a net sale of 903,072 shares. During the past 18 months, 2,942,609 shares of Kymera Therapeutics Inc () were sold and 455,112 shares were bought by its insiders, resulting in a net sale of 2,487,497 shares.
Kymera Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Kymera Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Principia Biopharma Inc do?
Who are the key executives at Principia Biopharma Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include Chief Medical Officer Dolca Thomas , Chief Development Officer Stefani Wolff , and Chief Scientific Officer David M Goldstein .
Principia Biopharma Inc () Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Principia Biopharma Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Principia Biopharma Inc Insider Transactions
- Download to Excel(.xls)
What does IDEAYA Biosciences Inc do?
Who are the key executives at IDEAYA Biosciences Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of IDEAYA Biosciences Inc. Other key executives at IDEAYA Biosciences Inc include director & President and CEO Yujiro S Hata , See Remarks Briseno Andres Ruiz , and VP & General Counsel Jason Throne .
IDEAYA Biosciences Inc () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in IDEAYA Biosciences Inc (). Other recent insider transactions involving IDEAYA Biosciences Inc () include a net sale of 38,970 shares made by Jason Throne , a net sale of 10,000 shares made by Briseno Andres Ruiz , and a net sale of 250,000 shares made by Yujiro S Hata .
In summary, during the past 3 months, insiders sold 104,000 shares of IDEAYA Biosciences Inc () in total and bought 0 shares, with a net sale of 104,000 shares. During the past 18 months, 311,470 shares of IDEAYA Biosciences Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 311,470 shares.
IDEAYA Biosciences Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
IDEAYA Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does CTI BioPharma Corp do?
Who are the key executives at CTI BioPharma Corp?
Bvf I Gp Llc is the 10 percent owner of CTI BioPharma Corp. Other key executives at CTI BioPharma Corp include EVP & Chief Commercial Officer James K Fong , director & President and CEO Adam R Craig , and EVP & Chief Financial Officer David Kirske .
CTI BioPharma Corp () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in CTI BioPharma Corp (). Other recent insider transactions involving CTI BioPharma Corp () include a net sale of 327,617 shares made by Adam R Craig , a net sale of 100,000 shares made by James K Fong , and a net sale of 91,500 shares made by Michael A Metzger .
In summary, during the past 3 months, insiders sold 0 shares of CTI BioPharma Corp () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 573,159 shares of CTI BioPharma Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 573,159 shares.
CTI BioPharma Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.
CTI BioPharma Corp Insider Transactions
- Download to Excel(.xls)
What does XOMA Corp do?
Who are the key executives at XOMA Corp?
Bvf I Gp Llc is the 10 percent owner of XOMA Corp. Other key executives at XOMA Corp include Chief Investment Officer Bradley Sitko , director & Interim CEO Owen Hughes , and 10 percent owner Bvf Ii Gp Llc .
XOMA Corp () Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of XOMA Corp () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XOMA Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
XOMA Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.
XOMA Corp Insider Transactions
- Download to Excel(.xls)
What does Cytokinetics Inc do?
Who are the key executives at Cytokinetics Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Cytokinetics Inc. Other key executives at Cytokinetics Inc include SVP Research & Early Dev Fady Ibraham Malik , EVP & Corp. Development & CBO Robert I Blum , and VP & Chief Accounting Officer Robert Wong .
Cytokinetics Inc () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Cytokinetics Inc (). Other recent insider transactions involving Cytokinetics Inc () include a net sale of 322,500 shares made by Robert I Blum , a net sale of 135,675 shares made by Fady Ibraham Malik , and a net sale of 16,624 shares made by John T Henderson .
In summary, during the past 3 months, insiders sold 82,710 shares of Cytokinetics Inc () in total and bought 0 shares, with a net sale of 82,710 shares. During the past 18 months, 522,157 shares of Cytokinetics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 522,157 shares.
Cytokinetics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Cytokinetics Inc Insider Transactions
- Download to Excel(.xls)
What does Infinity Pharmaceuticals Inc do?
Who are the key executives at Infinity Pharmaceuticals Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Infinity Pharmaceuticals Inc. Other key executives at Infinity Pharmaceuticals Inc include director & President & CEO Adelene Q Perkins , Chief Scientific Officer Stephane Peluso , and Chief Medical Officer Robert Jr. Ilaria .
Infinity Pharmaceuticals Inc () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Infinity Pharmaceuticals Inc (). Other recent insider transactions involving Infinity Pharmaceuticals Inc () include a net sale of 410,196 shares made by Adelene Q Perkins ,
In summary, during the past 3 months, insiders sold 0 shares of Infinity Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 410,196 shares of Infinity Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 410,196 shares.
Infinity Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Infinity Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does GlycoMimetics Inc do?
Who are the key executives at GlycoMimetics Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of GlycoMimetics Inc. Other key executives at GlycoMimetics Inc include Chief Medical Officer Edwin Rock , CFO Brian M. Hahn , and SVP & Chief Commercial Officer Bruce S Johnson .
GlycoMimetics Inc () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in GlycoMimetics Inc (). Other recent insider transactions involving GlycoMimetics Inc () include a net purchase of 2,026,717 shares made by Invus Public Equities, L.p. , a net sale of 4,121,511 shares made by Scott D Sandell , and a net purchase of 375,403 shares made by Edwin Rock .
In summary, during the past 3 months, insiders sold 0 shares of GlycoMimetics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,125,211 shares of GlycoMimetics Inc () were sold and 2,581,565 shares were bought by its insiders, resulting in a net sale of 1,543,646 shares.
GlycoMimetics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
GlycoMimetics Inc Insider Transactions
- Download to Excel(.xls)
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in CytomX Therapeutics Inc (). Other recent insider transactions involving CytomX Therapeutics Inc () include a net sale of 55,496 shares made by Sean A. Mccarthy , a net sale of 16,868 shares made by Lloyd A Rowland , and a net sale of 16,235 shares made by Jeffrey B Landau .
In summary, during the past 3 months, insiders sold 47,819 shares of CytomX Therapeutics Inc () in total and bought 0 shares, with a net sale of 47,819 shares. During the past 18 months, 121,072 shares of CytomX Therapeutics Inc () were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 116,072 shares.
CytomX Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Verastem Inc do?
Who are the key executives at Verastem Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Verastem Inc. Other key executives at Verastem Inc include Vice President of Finance Daniel Calkins , Chief Financial Officer Robert E. Gagnon , and Chief Operating Officer Dan Paterson .
Verastem Inc () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Verastem Inc (). Other recent insider transactions involving Verastem Inc () include a net sale of 2,240 shares made by Daniel Calkins , a net sale of 39,211 shares made by Robert E. Gagnon , and a net sale of 41,587 shares made by Brian M Stuglik .
In summary, during the past 3 months, insiders sold 10,939 shares of Verastem Inc () in total and bought 0 shares, with a net sale of 10,939 shares. During the past 18 months, 108,848 shares of Verastem Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 108,848 shares.
Verastem Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Verastem Inc Insider Transactions
- Download to Excel(.xls)
What does Rain Oncology Inc do?
Who are the key executives at Rain Oncology Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Rain Oncology Inc. Other key executives at Rain Oncology Inc include 10 percent owner Kevin C Tang , Principal Fin. & Acc. Officer Josephine Bruce , and 10 percent owner Tang Capital Management Llc .
Rain Oncology Inc () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Rain Oncology Inc (). Other recent insider transactions involving Rain Oncology Inc () include a net purchase of 1,198,445 shares made by Kevin C Tang , a net purchase of 164,881 shares made by Franklin M Berger , and a net purchase of 1,710,358 shares made by Biotechnology Value Fund L P .
In summary, during the past 3 months, insiders sold 0 shares of Rain Oncology Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,168,973 shares of Rain Oncology Inc () were sold and 4,219,869 shares were bought by its insiders, resulting in a net purchase of 3,050,896 shares.
Rain Oncology Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Rain Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Olema Pharmaceuticals inc do?
Who are the key executives at Olema Pharmaceuticals inc?
Bvf I Gp Llc is the 10 percent owner of Olema Pharmaceuticals inc. Other key executives at Olema Pharmaceuticals inc include director & Chief Technology Officer Cyrus Harmon , 10 percent owner Paradigm Biocapital Advisors Lp , and director & President and CEO Sean Bohen .
Olema Pharmaceuticals inc () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Olema Pharmaceuticals inc (). Other recent insider transactions involving Olema Pharmaceuticals inc () include a net sale of 263,181 shares made by Cyrus Harmon , a net sale of 44,370 shares made by David C. Myles , and a net sale of 8,742 shares made by Kovacs Shane William Charles .
In summary, during the past 3 months, insiders sold 75,000 shares of Olema Pharmaceuticals inc () in total and bought 0 shares, with a net sale of 75,000 shares. During the past 18 months, 398,074 shares of Olema Pharmaceuticals inc () were sold and 2,255,932 shares were bought by its insiders, resulting in a net purchase of 1,857,858 shares.
Olema Pharmaceuticals inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Olema Pharmaceuticals inc Insider Transactions
- Download to Excel(.xls)
What does Cullinan Oncology Inc do?
Who are the key executives at Cullinan Oncology Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Cullinan Oncology Inc. Other key executives at Cullinan Oncology Inc include Acting Chief Business Officer Savill Corrine , director & President and CEO Nadim Ahmed , and Chief Legal Officer Jacquelyn L Sumer .
Cullinan Oncology Inc () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Cullinan Oncology Inc (). Other recent insider transactions involving Cullinan Oncology Inc () include a net sale of 19,949 shares made by Jennifer Michaelson , a net sale of 6,823 shares made by Jeffrey Trigilio , and a net sale of 3,809 shares made by Jeffrey Alan Jones .
In summary, during the past 3 months, insiders sold 120,000 shares of Cullinan Oncology Inc () in total and bought 0 shares, with a net sale of 120,000 shares. During the past 18 months, 160,608 shares of Cullinan Oncology Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 160,608 shares.
Cullinan Oncology Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Cullinan Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Repare Therapeutics Inc do?
Who are the key executives at Repare Therapeutics Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Repare Therapeutics Inc. Other key executives at Repare Therapeutics Inc include EVP & Chief Medical Officer Maria Koehler , President and CEO Lloyd Mitchell Segal , and EVP & Chief Financial Officer Steve Forte .
Repare Therapeutics Inc () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Repare Therapeutics Inc (). Other recent insider transactions involving Repare Therapeutics Inc () include a net sale of 12,683 shares made by Michael Zinda , a net purchase of 2,011,010 shares made by Biotechnology Value Fund L P , and a net sale of 13,091 shares made by Lloyd Mitchell Segal .
In summary, during the past 3 months, insiders sold 21,690 shares of Repare Therapeutics Inc () in total and bought 0 shares, with a net sale of 21,690 shares. During the past 18 months, 282,163 shares of Repare Therapeutics Inc () were sold and 2,011,010 shares were bought by its insiders, resulting in a net purchase of 1,728,847 shares.
Repare Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Repare Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does MoonLake Immunotherapeutics do?
Who are the key executives at MoonLake Immunotherapeutics?
Bvf I Gp Llc is the director & 10 percent owner of MoonLake Immunotherapeutics. Other key executives at MoonLake Immunotherapeutics include director & Chief Executive Officer Santos Da Silva Jorge , Chief Scientific Officer Kristian Reich , and Chief Financial Officer Matthias Bodenstedt .
MoonLake Immunotherapeutics () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in MoonLake Immunotherapeutics (). Other recent insider transactions involving MoonLake Immunotherapeutics () include a net purchase of 1,629,151 shares made by Bihua Chen , a net sale of 200,000 shares made by Kristian Reich , and a net sale of 184,740 shares made by Santos Da Silva Jorge .
In summary, during the past 3 months, insiders sold 384,740 shares of MoonLake Immunotherapeutics () in total and bought 0 shares, with a net sale of 384,740 shares. During the past 18 months, 484,740 shares of MoonLake Immunotherapeutics () were sold and 1,629,151 shares were bought by its insiders, resulting in a net purchase of 1,144,411 shares.
MoonLake Immunotherapeutics ()'s detailed insider trading history can be found in Insider Trading Tracker table.
MoonLake Immunotherapeutics Insider Transactions
- Download to Excel(.xls)
What does 4D Molecular Therapeutics Inc do?
Who are the key executives at 4D Molecular Therapeutics Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of 4D Molecular Therapeutics Inc. Other key executives at 4D Molecular Therapeutics Inc include Chief Legal and HR Officer Scott Bizily , director & Chief Executive Officer David Kirn , and Chief Medical Officer Robert Young Kim .
4D Molecular Therapeutics Inc () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in 4D Molecular Therapeutics Inc (). Other recent insider transactions involving 4D Molecular Therapeutics Inc () include a net sale of 39,387 shares made by Scott Bizily , a net sale of 340,847 shares made by David Kirn , and a net purchase of 310,000 shares made by Viking Global Investors Lp .
In summary, during the past 3 months, insiders sold 149,638 shares of 4D Molecular Therapeutics Inc () in total and bought 0 shares, with a net sale of 149,638 shares. During the past 18 months, 949,786 shares of 4D Molecular Therapeutics Inc () were sold and 850,000 shares were bought by its insiders, resulting in a net sale of 99,786 shares.
4D Molecular Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
4D Molecular Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does ESSA Pharma Inc do?
Who are the key executives at ESSA Pharma Inc?
Bvf I Gp Llc is the 10 percent owner of ESSA Pharma Inc. Other key executives at ESSA Pharma Inc include Chief Operating Officer Peter Virsik , director & Chief Executive Officer David Ross Parkinson , and Chief Financial Officer David S. Wood .
ESSA Pharma Inc () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in ESSA Pharma Inc (). Other recent insider transactions involving ESSA Pharma Inc () include a net sale of 77,781 shares made by Peter Virsik , a net purchase of 99,730 shares made by Franklin M Berger , and a net purchase of 33,657 shares made by David Ross Parkinson .
In summary, during the past 3 months, insiders sold 75,364 shares of ESSA Pharma Inc () in total and bought 0 shares, with a net sale of 75,364 shares. During the past 18 months, 77,781 shares of ESSA Pharma Inc () were sold and 2,133,387 shares were bought by its insiders, resulting in a net purchase of 2,055,606 shares.
ESSA Pharma Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
ESSA Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does Third Harmonic Bio Inc do?
Who are the key executives at Third Harmonic Bio Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Third Harmonic Bio Inc. Other key executives at Third Harmonic Bio Inc include director & CEO Natalie C. Holles , Chief Administrative Officer Julie Person , and Chief Medical Officer Edward R. Conner .
Third Harmonic Bio Inc () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Third Harmonic Bio Inc (). Other recent insider transactions involving Third Harmonic Bio Inc () include a net sale of 13,970 shares made by Julie Person , a net purchase of 214,063 shares made by Biotechnology Value Fund L P , and a net sale of 13,558 shares made by Natalie C. Holles .
In summary, during the past 3 months, insiders sold 14,665 shares of Third Harmonic Bio Inc () in total and bought 0 shares, with a net sale of 14,665 shares. During the past 18 months, 32,318 shares of Third Harmonic Bio Inc () were sold and 214,063 shares were bought by its insiders, resulting in a net purchase of 181,745 shares.
Third Harmonic Bio Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Third Harmonic Bio Inc Insider Transactions
- Download to Excel(.xls)
What does Structure Therapeutics Inc do?
Who are the key executives at Structure Therapeutics Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of Structure Therapeutics Inc. Other key executives at Structure Therapeutics Inc include other: See Explanation of Responses Biotechnology Value Fund L P , 10 percent owner Bvf Gp Holdings Llc , and other: See Explanation of Responses Bvf Ii Gp Llc .
Structure Therapeutics Inc () Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Structure Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Structure Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Structure Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Structure Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Pieris Pharmaceuticals Inc do?
Who are the key executives at Pieris Pharmaceuticals Inc?
Bvf I Gp Llc is the 10 percent owner of Pieris Pharmaceuticals Inc. Other key executives at Pieris Pharmaceuticals Inc include 10 percent owner Bvf Gp Holdings Llc , other: See Explanation of Responses Bvf Ii Gp Llc , and Chief Development Officer Shane Olwill .
Pieris Pharmaceuticals Inc () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in Pieris Pharmaceuticals Inc (). Other recent insider transactions involving Pieris Pharmaceuticals Inc () include a net purchase of 10,000 shares made by Christopher P Kiritsy ,
In summary, during the past 3 months, insiders sold 0 shares of Pieris Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pieris Pharmaceuticals Inc () were sold and 10,000 shares were bought by its insiders, resulting in a net purchase of 10,000 shares.
Pieris Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Pieris Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does POINT Biopharma Global Inc do?
Who are the key executives at POINT Biopharma Global Inc?
Bvf I Gp Llc is the other: See Explanation of Responses of POINT Biopharma Global Inc. Other key executives at POINT Biopharma Global Inc include other: See Explanation of Responses Biotechnology Value Fund L P , 10 percent owner Bvf Partners L P/il , and 10 percent owner Bvf Gp Holdings Llc .
POINT Biopharma Global Inc () Insider Trades Summary
Over the past 18 months, Bvf I Gp Llc made no insider transaction in POINT Biopharma Global Inc (). Other recent insider transactions involving POINT Biopharma Global Inc () include a net sale of 17,161,278 shares made by Biotechnology Value Fund L P , a net purchase of 50,000 shares made by Allan C Silber , and a net purchase of 6,000 shares made by Jonathan R. Goodman .
In summary, during the past 3 months, insiders sold 0 shares of POINT Biopharma Global Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,161,278 shares of POINT Biopharma Global Inc () were sold and 70,830 shares were bought by its insiders, resulting in a net sale of 17,090,448 shares.
POINT Biopharma Global Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
POINT Biopharma Global Inc Insider Transactions
- Download to Excel(.xls)
Bvf I Gp Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Bvf I Gp Llc. You might contact Bvf I Gp Llc via mailing address: 44 Montgomery St., 40th Floor, San Francisco Ca 94104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey